$HUMA news
The latest HUMA stock news: headlines, filings, AI summaries and sentiment for $HUMA, updated around the clock.
- Humacyte Reports Q3 2026 Revenue Growth Driven by Symvess Adoption
- Humacyte, Inc. - 10-Q Filing
- Humacyte Plans November Dialysis sBLA Filing and Projects Q4 Symvess Sales Growth
- Humacyte Reports Third Quarter Earnings Beat on Revenue and EPS
- Humacyte, Inc. - 8-K Filing
- Humacyte (HUMA) Scheduled to Report Q3 2026 Earnings Results
- Stocks Making Significant Moves Midday: T-Mobile, Verizon, AT&T, Crown Castle, Teva & More
- Humacyte, Inc. - 8-K Filing
- Thyme Care Raises $125 Million in Series E Funding at Over $2 Billion Valuation
- Thyme Care Secures Over $125M Series E Funding at a Valuation Exceeding $2B
- Humacyte Reports Positive Interim Results from Phase III Trial for Dialysis Access Vessel
- Humacyte Reports Q2 2026 Financials, Advances Clinical Trials
- Humacyte, Inc. - 8-K Filing
- Humana Exceeds Quarterly Earnings Estimates with Controlled Medical Costs
- 70-Year-Old Missouri Woman Hospitalized After Medicare Advantage Denies $8K/Month Drug Coverage
- Stocks Making Significant Moves Midday: Alnylam, Blackstone, Broadcom, Five Below and Others
- Humacyte Reports Q1 2025 Earnings and Business Update
- Humacyte Reports Q1 2025 Earnings and Commercial Progress
- Summus Appoints Mike Tilton as Chief Commercial Officer
- Humacyte, Inc. - 8-K Filing